Top Markets
#1 Black Phoenix Black Phoenix +827.56%
#2 YFSX YFSX +35.49%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.20%
#4 Not in Employment, Education, or Training Not in Employment, Education, or Training +25.44%
#5 Beam Beam +23.28%
#6 SAFEcoin SAFEcoin +20.74%
#7 pipedog pipedog +18.54%
#8 Magma Finance Magma Finance +17.16%
#9 Bless Bless +16.79%
#10 THORChain THORChain +15.51%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Alamar Biosciences, Inc. Alamar Biosciences, Inc.

Alamar Biosciences, Inc.

ALMR
Rank in Stocks #5889
Alamar Biosciences operates as a commercial-stage proteomics firm, specializing... Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately quantifying multiple proteins, particularly those present in low concentrations, across a wide array of research and potential clinical uses.
Share Price
$34.71
Market Cap
$2.41B
Change (1 day)
1.85%
Change (1 year)
-
Country
US
Trade Alamar Biosciences, Inc. (ALMR)

Category

Healthcare
Earnings for Alamar Biosciences, Inc. (ALMR)
Earnings in 2026 TTM: 0
According to Alamar Biosciences, Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Alamar Biosciences, Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH